Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Vasileios TatanisDepartment of Urology, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-8584-3888
Dimitris VeroutisMolecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 11527 Athens, Greece.
Pavlos PantelisMolecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 11527 Athens, Greece.
George TheocharousMolecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 11527 Athens, Greece.ORCID 0009-0008-4518-8728
Helen SarlanisDepartment of Pathology, Medical School, National and Kapodistrian University, 10680 Athens, Greece.ORCID 0000-0001-7197-939X
Alexandros GeorgiouDepartment of Pathology, Medical School, National and Kapodistrian University, 10680 Athens, Greece.
Francesk MulitaDepartment of Surgery, University Hospital of Patras, 26504 Patras, Greece.ORCID 0000-0001-7198-2628
Angelis PeteinarisDepartment of Urology, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-0427-4506
Anastasios NatsosDepartment of Urology, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-5845-7420
Napoleon Moulavasilis1st Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, 10680 Athens, Greece.ORCID 0000-0002-1820-9027
Nikolaos KavantzasDepartment of Pathology, Medical School, National and Kapodistrian University, 10680 Athens, Greece.
Athanassios KotsinasMolecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 11527 Athens, Greece.ORCID 0000-0003-2397-4118
Ioannis Adamakis1st Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, 10680 Athens, Greece.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
Cellular SenescenceNeoplasms, Germ Cell and EmbryonalTesticular NeoplasmsAdultHumansImmunohistochemistryMaleMiddle AgedOrchiectomygerm cell neoplasia in situGL13immunohistochemistrysenescencetesticular cancer
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Cellular Senescence in Germ Cell Neoplasia In Situ (GCNIS) and Other Histological Types of Testicular Cancer. · full record | Socratic